Myeloma Rounds Philadelphia
June 18, 2024
Format
Live, In-Person Event
*Pre-registration required
Live interactive continuing medical education activity for healthcare professionals in Philadelphia and surrounding areas to discuss multiple myeloma updates and challenges in treatment.
Target Audience
This activity is intended for hematologists-oncologists, medical oncologists, physician associates, nurse practitioners, nurses and pharmacists involved in the care of patients with myeloma.
Agenda
6:30 PM – Dinner and Networking
7:00 PM – Welcome and Overview of Program
Edward A. Stadtmauer, MD
7:05 PM – Overview of LLS Resources
Amanda O’Neill, LMSW, and Ruby Nava-Ramos, MPH
7:10 PM – Updates on Multiple Myeloma Clinical Trials in 2024
Adam Cohen, MD
7:25 PM– Case Presentation and Discussion on Early Line CAR-T in Multiple Myeloma
Asya Varshavsky-Yanovsky, MD, PhD and Daniel (Tuck) Stapor, MD
7:55 PM – Case Presentation and Discussion on MRD Testing in Newly Diagnosed Myeloma: Why, When, and for How Long?
Adam Binder, MD and Ian Landry, MD
8:25 PM – Case Presentation and Discussion on Recurrent AL Amyloidoma
Tulin Budak-Alpdogan, MD and Ted Raddell, MD
8:55 PM – Discussion and Wrap-up
All Faculty
9:00 PM – Conclusion
Educational Objectives
At the conclusion of this activity, participants will be better able to:
- Describe the latest developments in myeloma, including current and emerging treatments
- Engage patients and caregivers in clinical trials discussions on newly approved therapies and emerging therapies for myeloma, including combination therapies, CAR T-cell therapy and bi-specific antibodies
- Identify disparities and challenges in diagnosis and treatment of myeloma
- Apply evidence-based treatment strategies for optimal patient care
- Access patient support resources
Advisory Group
Edward A. Stadtmauer, MD (Chair)
University of Pennsylvania
Abramson Cancer Center
Philadelphia, PA
Adam Binder, MD
Thomas Jefferson University Hospital
Philadelphia, PA
Tulin Budak-Alpdogan, MD
Cooper University Health Care
Camden, NJ
Oxana Megherea, PharmD, BCOP
University of Pennsylvania
Abramson Cancer Center
Philadelphia, PA
Asya Varshavsky-Yanovsky, MD, PhD
Temple University Health System
Fox Chase Cancer Center
Philadelphia, PA
Adam Waxman, MD, MS
University of Pennsylvania
Abramson Cancer Center
Philadelphia, PA
Faculty
Edward A. Stadtmauer, MD (Chair)
University of Pennsylvania
Abramson Cancer Center
Philadelphia, PA
Adam Binder, MD
Thomas Jefferson University Hospital
Philadelphia, PA
Tulin Budak-Alpdogan, MD
Cooper University Health Care
Camden, NJ
Adam Cohen, MD
University of Pennsylvania
Abramson Cancer Center
Philadelphia, PA
Ian Landry, MD
Thomas Jefferson University Hospital
Philadelphia, PA
Ruby Nava-Ramos, MPH
The Leukemia & Lymphoma Society
Rye Brook, NY
Amanda O'Neill, LMSW
The Leukemia & Lymphoma Society
Rye Brook, NY
Ted Raddell, MD
Cooper University Health Care
Camden, NJ
Daniel (Tuck) Stapor, MD
Temple University Health System
Fox Chase Cancer Center
Philadelphia, PA
Asya Varshavsky-Yanovsky, MD
Temple University Health System
Fox Chase Cancer Center
Philadelphia, PA
Continuing Education Information
Accreditation, Credit and Support
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc. and The Leukemia & Lymphoma Society. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associate
Medical Learning Institute, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Pharmacy Education
Medical Learning Institute, Inc. designates this continuing education activity for 2.0 contact hours (0.2 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: JA0007322-9999-24-049-L01-P
Type of Activity: Application
Nursing Continuing Professional Development Contact Hours
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 2.0 continuing education contact hour through the California Board of Registered Nursing.
Interprofessional Continuing Education Credit
This activity was planned by and for the healthcare team, and learners will receive 2.0 Interprofessional Continuing Education (IPCE) credits for learning and change.
Method of Participation
There are no fees for participating in or receiving credits for this CE activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
In order to receive credit, learners must participate in the entire CE activity, complete the activity evaluation form and return it to staff at the end of the program. A certificate of completion will be emailed within 30 days of receipt. If you have questions regarding the receipt of your certificate, please contact us via email at ndane@mlieducation.org.
For Pharmacists, Medical Learning Institute will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/
Providers
This activity is provided by The Leukemia & Lymphoma Society and Medical Learning Institute, Inc., in collaboration with the Association of Cancer Care Centers™ (ACCC).
Supporters
Supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: profeducation@LLS.org.